BlueYard Capital
Signal active
Investment Firm
Overview
BlueYard invests in founders with transforming ideas that decentralize markets and empower humanity. Typically $1-3m as an initial investment; active around the world. Most active in crypto / web 3 (e.g. Protocol Labs, Filecoin, Open Zeppelin, Radicle), technologies that help us overcome our largest planetary challenges (e.g. Marvel Fusion, Meatable, Dance), frontier biology to help us live long and prosper (e.g. BitBio, Biofidelity) and vertical software un-bundling monopolies (e.g. Pitch, Wonder).
Highlights
Founded
2016
Industry
Venture Capital
Employees
11-50
Investment
76
Lead Investment
31
Exits
1
Stages
Seed, Early Stage Venture
Investor Type
Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
BlueYard Capital, established in 2016 and headquartered in Europe., specializes in Seed, Early Stage Venture investments across Enterprise Software, Real Time, Apps, PaaS, Internet of Things, Internet, Infrastructure, Content Delivery Network, Video Streaming, Analytics. The organization boasts a portfolio of 76 investments, with an average round size of $12.6M and 1 successful exits. Their recent investments include deepstreamHub, Greta, VECTARY, Neulogy Ventures, OpenBazaar. The highest investment round they participated in was $54.8B. Among their most notable exits are deepstreamHub and Greta. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
BlueYard Capital has made 76 investments. Their most recent investment was on May 29, 2024, when ExpressionEdits raised $13.0M.
BlueYard Capital has made 4 diversity investments. Their most recent diversity investment was on Apr 29, 2024, when Transcripta Bio raised $10.0M.
investments
76
Diversity investments
4
Lead investments
31
Number of exits
1
Investments
76
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 03, 2024 | Biofidelity | Biotechnology | 24.0M |
| Apr 29, 2024 | Transcripta Bio | Biotechnology | 10.0M |
| May 08, 2024 | Insempra | Biotechnology | 20.0M |
| May 29, 2024 | ExpressionEdits | Biotechnology | 13.0M |
Exits
1
Funding Timeline
Funding rounds
76
Investors
0
Funds
3
Funding Rounds
76
BlueYard Capital has raised 76 rounds. Their latest funding was raised on May 29, 2024 from a Seed Round - ExpressionEdits round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 03, 2024 | Venture Round - Biofidelity | - | 24.0M | - |
| Apr 29, 2024 | Venture Round - Transcripta Bio | - | 10.0M | - |
| May 08, 2024 | Series A - Insempra | - | 20.0M | - |
| May 29, 2024 | Seed Round - ExpressionEdits | - | 13.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.